Central Facility for Recombinant Cells and Sensors

• 02 Mar 2026

On 1st March 2026, Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh inaugurated the “Central Facility for Recombinant Cells and Sensors” at BRIC-Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB), Thiruvananthapuram.

• The facility has been developed by the Department of Biotechnology (DBT) at a cost of approximately ₹60 crore.
• It is expected to strengthen drug discovery, medical research and agricultural genomics in India.
• The facility houses engineered recombinant cells and advanced screening systems to accelerate target-specific drug discovery.
• It will serve academia, industry and healthcare innovators nationwide, enabling faster translation of laboratory research into therapeutics.
• A dedicated Good Manufacturing Practice (GMP) facility was also announced at BRIC-RGCB, with a total DBT investment of ₹80 crore in two phases.
• The GMP facility will support pre-commercial production of biologics and advanced cell-based therapies, including CAR-T therapy.